nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A5—Teniposide—lymphatic system cancer	0.125	0.201	CbGbCtD
Fentanyl—CYP3A7—Vincristine—lymphatic system cancer	0.0802	0.129	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0802	0.129	CbGbCtD
Fentanyl—CYP3A5—Vincristine—lymphatic system cancer	0.0602	0.0969	CbGbCtD
Fentanyl—ABCB1—Mitoxantrone—lymphatic system cancer	0.0569	0.0916	CbGbCtD
Fentanyl—CYP3A4—Cytarabine—lymphatic system cancer	0.0495	0.0797	CbGbCtD
Fentanyl—CYP3A4—Teniposide—lymphatic system cancer	0.0487	0.0785	CbGbCtD
Fentanyl—ABCB1—Vincristine—lymphatic system cancer	0.0392	0.063	CbGbCtD
Fentanyl—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0341	0.0549	CbGbCtD
Fentanyl—ABCB1—Methotrexate—lymphatic system cancer	0.0237	0.0382	CbGbCtD
Fentanyl—CYP3A4—Vincristine—lymphatic system cancer	0.0235	0.0378	CbGbCtD
Fentanyl—Back pain—Vincristine—lymphatic system cancer	0.000338	0.000893	CcSEcCtD
Fentanyl—Vomiting—Teniposide—lymphatic system cancer	0.000338	0.000892	CcSEcCtD
Fentanyl—Sepsis—Methotrexate—lymphatic system cancer	0.000337	0.000889	CcSEcCtD
Fentanyl—Agitation—Carmustine—lymphatic system cancer	0.000337	0.000888	CcSEcCtD
Fentanyl—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000335	0.000885	CcSEcCtD
Fentanyl—Asthenia—Fludarabine—lymphatic system cancer	0.000335	0.000884	CcSEcCtD
Fentanyl—Rash—Teniposide—lymphatic system cancer	0.000335	0.000884	CcSEcCtD
Fentanyl—Dermatitis—Teniposide—lymphatic system cancer	0.000335	0.000884	CcSEcCtD
Fentanyl—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000333	0.00088	CcSEcCtD
Fentanyl—Headache—Teniposide—lymphatic system cancer	0.000333	0.000879	CcSEcCtD
Fentanyl—Pruritus—Fludarabine—lymphatic system cancer	0.00033	0.000872	CcSEcCtD
Fentanyl—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00033	0.000871	CcSEcCtD
Fentanyl—Back pain—Mitoxantrone—lymphatic system cancer	0.000329	0.000869	CcSEcCtD
Fentanyl—Leukopenia—Carmustine—lymphatic system cancer	0.000328	0.000865	CcSEcCtD
Fentanyl—Anorexia—Bleomycin—lymphatic system cancer	0.000326	0.000862	CcSEcCtD
Fentanyl—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000325	0.000859	CcSEcCtD
Fentanyl—Anaemia—Vincristine—lymphatic system cancer	0.000323	0.000853	CcSEcCtD
Fentanyl—Agitation—Vincristine—lymphatic system cancer	0.000321	0.000848	CcSEcCtD
Fentanyl—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000321	0.000847	CcSEcCtD
Fentanyl—Polyuria—Methotrexate—lymphatic system cancer	0.000321	0.000847	CcSEcCtD
Fentanyl—Hypotension—Bleomycin—lymphatic system cancer	0.00032	0.000845	CcSEcCtD
Fentanyl—Diarrhoea—Fludarabine—lymphatic system cancer	0.00032	0.000843	CcSEcCtD
Fentanyl—Convulsion—Carmustine—lymphatic system cancer	0.000317	0.000838	CcSEcCtD
Fentanyl—Hypertension—Carmustine—lymphatic system cancer	0.000316	0.000835	CcSEcCtD
Fentanyl—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000316	0.000834	CcSEcCtD
Fentanyl—Nausea—Teniposide—lymphatic system cancer	0.000316	0.000833	CcSEcCtD
Fentanyl—Anaemia—Mitoxantrone—lymphatic system cancer	0.000315	0.000831	CcSEcCtD
Fentanyl—Vertigo—Vincristine—lymphatic system cancer	0.000314	0.000829	CcSEcCtD
Fentanyl—Leukopenia—Vincristine—lymphatic system cancer	0.000313	0.000826	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000312	0.000823	CcSEcCtD
Fentanyl—Chest pain—Carmustine—lymphatic system cancer	0.000312	0.000823	CcSEcCtD
Fentanyl—Myalgia—Carmustine—lymphatic system cancer	0.000312	0.000823	CcSEcCtD
Fentanyl—Anxiety—Carmustine—lymphatic system cancer	0.000311	0.00082	CcSEcCtD
Fentanyl—Paraesthesia—Bleomycin—lymphatic system cancer	0.000308	0.000812	CcSEcCtD
Fentanyl—Malaise—Mitoxantrone—lymphatic system cancer	0.000307	0.00081	CcSEcCtD
Fentanyl—Dyspnoea—Bleomycin—lymphatic system cancer	0.000305	0.000806	CcSEcCtD
Fentanyl—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000305	0.000804	CcSEcCtD
Fentanyl—Convulsion—Vincristine—lymphatic system cancer	0.000303	0.0008	CcSEcCtD
Fentanyl—Hypertension—Vincristine—lymphatic system cancer	0.000302	0.000797	CcSEcCtD
Fentanyl—Confusional state—Carmustine—lymphatic system cancer	0.000301	0.000796	CcSEcCtD
Fentanyl—Oedema—Carmustine—lymphatic system cancer	0.000299	0.000789	CcSEcCtD
Fentanyl—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000299	0.000788	CcSEcCtD
Fentanyl—Decreased appetite—Bleomycin—lymphatic system cancer	0.000298	0.000786	CcSEcCtD
Fentanyl—Myalgia—Vincristine—lymphatic system cancer	0.000298	0.000786	CcSEcCtD
Fentanyl—Visual disturbance—Methotrexate—lymphatic system cancer	0.000297	0.000785	CcSEcCtD
Fentanyl—Cough—Mitoxantrone—lymphatic system cancer	0.000297	0.000784	CcSEcCtD
Fentanyl—Infection—Carmustine—lymphatic system cancer	0.000297	0.000784	CcSEcCtD
Fentanyl—Vomiting—Fludarabine—lymphatic system cancer	0.000297	0.000784	CcSEcCtD
Fentanyl—Convulsion—Mitoxantrone—lymphatic system cancer	0.000295	0.000779	CcSEcCtD
Fentanyl—Rash—Fludarabine—lymphatic system cancer	0.000294	0.000777	CcSEcCtD
Fentanyl—Dermatitis—Fludarabine—lymphatic system cancer	0.000294	0.000777	CcSEcCtD
Fentanyl—Hypertension—Mitoxantrone—lymphatic system cancer	0.000294	0.000776	CcSEcCtD
Fentanyl—Pain—Bleomycin—lymphatic system cancer	0.000293	0.000773	CcSEcCtD
Fentanyl—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000293	0.000772	CcSEcCtD
Fentanyl—Headache—Fludarabine—lymphatic system cancer	0.000293	0.000772	CcSEcCtD
Fentanyl—Tachycardia—Carmustine—lymphatic system cancer	0.000292	0.00077	CcSEcCtD
Fentanyl—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000291	0.000768	CcSEcCtD
Fentanyl—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00029	0.000765	CcSEcCtD
Fentanyl—Chest pain—Mitoxantrone—lymphatic system cancer	0.00029	0.000765	CcSEcCtD
Fentanyl—Myalgia—Mitoxantrone—lymphatic system cancer	0.00029	0.000765	CcSEcCtD
Fentanyl—Anxiety—Mitoxantrone—lymphatic system cancer	0.000289	0.000762	CcSEcCtD
Fentanyl—Lethargy—Methotrexate—lymphatic system cancer	0.000287	0.000759	CcSEcCtD
Fentanyl—Discomfort—Mitoxantrone—lymphatic system cancer	0.000286	0.000756	CcSEcCtD
Fentanyl—Oedema—Vincristine—lymphatic system cancer	0.000285	0.000753	CcSEcCtD
Fentanyl—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000285	0.000753	CcSEcCtD
Fentanyl—Anorexia—Carmustine—lymphatic system cancer	0.000285	0.000752	CcSEcCtD
Fentanyl—Infection—Vincristine—lymphatic system cancer	0.000283	0.000748	CcSEcCtD
Fentanyl—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000282	0.000745	CcSEcCtD
Fentanyl—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000282	0.000744	CcSEcCtD
Fentanyl—Confusional state—Mitoxantrone—lymphatic system cancer	0.00028	0.00074	CcSEcCtD
Fentanyl—Nervous system disorder—Vincristine—lymphatic system cancer	0.00028	0.000739	CcSEcCtD
Fentanyl—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000279	0.000737	CcSEcCtD
Fentanyl—Hypotension—Carmustine—lymphatic system cancer	0.000279	0.000737	CcSEcCtD
Fentanyl—Oedema—Mitoxantrone—lymphatic system cancer	0.000278	0.000733	CcSEcCtD
Fentanyl—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000278	0.000733	CcSEcCtD
Fentanyl—Nausea—Fludarabine—lymphatic system cancer	0.000277	0.000732	CcSEcCtD
Fentanyl—Infection—Mitoxantrone—lymphatic system cancer	0.000276	0.000729	CcSEcCtD
Fentanyl—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000276	0.000728	CcSEcCtD
Fentanyl—Shock—Mitoxantrone—lymphatic system cancer	0.000273	0.000722	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000272	0.000719	CcSEcCtD
Fentanyl—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000272	0.000718	CcSEcCtD
Fentanyl—Urticaria—Bleomycin—lymphatic system cancer	0.000272	0.000718	CcSEcCtD
Fentanyl—Anorexia—Vincristine—lymphatic system cancer	0.000272	0.000718	CcSEcCtD
Fentanyl—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000271	0.000716	CcSEcCtD
Fentanyl—Body temperature increased—Bleomycin—lymphatic system cancer	0.000271	0.000715	CcSEcCtD
Fentanyl—Insomnia—Carmustine—lymphatic system cancer	0.00027	0.000714	CcSEcCtD
Fentanyl—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00027	0.000712	CcSEcCtD
Fentanyl—Irritability—Methotrexate—lymphatic system cancer	0.000269	0.00071	CcSEcCtD
Fentanyl—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000269	0.000709	CcSEcCtD
Fentanyl—Paraesthesia—Carmustine—lymphatic system cancer	0.000268	0.000708	CcSEcCtD
Fentanyl—Mood swings—Methotrexate—lymphatic system cancer	0.000267	0.000704	CcSEcCtD
Fentanyl—Hypotension—Vincristine—lymphatic system cancer	0.000267	0.000704	CcSEcCtD
Fentanyl—Dyspnoea—Carmustine—lymphatic system cancer	0.000267	0.000703	CcSEcCtD
Fentanyl—Somnolence—Carmustine—lymphatic system cancer	0.000266	0.000701	CcSEcCtD
Fentanyl—Anorexia—Mitoxantrone—lymphatic system cancer	0.000265	0.000699	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00026	0.000686	CcSEcCtD
Fentanyl—Decreased appetite—Carmustine—lymphatic system cancer	0.00026	0.000686	CcSEcCtD
Fentanyl—Hypotension—Mitoxantrone—lymphatic system cancer	0.00026	0.000685	CcSEcCtD
Fentanyl—Insomnia—Vincristine—lymphatic system cancer	0.000258	0.000681	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000258	0.000681	CcSEcCtD
Fentanyl—Paraesthesia—Vincristine—lymphatic system cancer	0.000256	0.000676	CcSEcCtD
Fentanyl—Pain—Carmustine—lymphatic system cancer	0.000256	0.000675	CcSEcCtD
Fentanyl—Constipation—Carmustine—lymphatic system cancer	0.000256	0.000675	CcSEcCtD
Fentanyl—Breast disorder—Methotrexate—lymphatic system cancer	0.000255	0.000672	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000253	0.000668	CcSEcCtD
Fentanyl—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000252	0.000666	CcSEcCtD
Fentanyl—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00025	0.000659	CcSEcCtD
Fentanyl—Decreased appetite—Vincristine—lymphatic system cancer	0.000248	0.000655	CcSEcCtD
Fentanyl—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000248	0.000654	CcSEcCtD
Fentanyl—Somnolence—Mitoxantrone—lymphatic system cancer	0.000247	0.000652	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000246	0.00065	CcSEcCtD
Fentanyl—Feeling abnormal—Carmustine—lymphatic system cancer	0.000246	0.00065	CcSEcCtD
Fentanyl—Fatigue—Vincristine—lymphatic system cancer	0.000246	0.000649	CcSEcCtD
Fentanyl—Asthenia—Bleomycin—lymphatic system cancer	0.000246	0.000648	CcSEcCtD
Fentanyl—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000245	0.000646	CcSEcCtD
Fentanyl—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000244	0.000645	CcSEcCtD
Fentanyl—Pain—Vincristine—lymphatic system cancer	0.000244	0.000644	CcSEcCtD
Fentanyl—Constipation—Vincristine—lymphatic system cancer	0.000244	0.000644	CcSEcCtD
Fentanyl—Asthma—Methotrexate—lymphatic system cancer	0.000243	0.000643	CcSEcCtD
Fentanyl—Pruritus—Bleomycin—lymphatic system cancer	0.000242	0.000639	CcSEcCtD
Fentanyl—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000242	0.000638	CcSEcCtD
Fentanyl—Fatigue—Mitoxantrone—lymphatic system cancer	0.00024	0.000632	CcSEcCtD
Fentanyl—Constipation—Mitoxantrone—lymphatic system cancer	0.000238	0.000627	CcSEcCtD
Fentanyl—Pain—Mitoxantrone—lymphatic system cancer	0.000238	0.000627	CcSEcCtD
Fentanyl—Abdominal pain—Carmustine—lymphatic system cancer	0.000236	0.000624	CcSEcCtD
Fentanyl—Body temperature increased—Carmustine—lymphatic system cancer	0.000236	0.000624	CcSEcCtD
Fentanyl—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000233	0.000616	CcSEcCtD
Fentanyl—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000233	0.000616	CcSEcCtD
Fentanyl—Pancytopenia—Methotrexate—lymphatic system cancer	0.000231	0.00061	CcSEcCtD
Fentanyl—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000229	0.000604	CcSEcCtD
Fentanyl—Dysuria—Methotrexate—lymphatic system cancer	0.000228	0.000601	CcSEcCtD
Fentanyl—Neutropenia—Methotrexate—lymphatic system cancer	0.000228	0.000601	CcSEcCtD
Fentanyl—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000227	0.0006	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000226	0.000597	CcSEcCtD
Fentanyl—Body temperature increased—Vincristine—lymphatic system cancer	0.000226	0.000595	CcSEcCtD
Fentanyl—Abdominal pain—Vincristine—lymphatic system cancer	0.000226	0.000595	CcSEcCtD
Fentanyl—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000224	0.000592	CcSEcCtD
Fentanyl—Urticaria—Mitoxantrone—lymphatic system cancer	0.000221	0.000583	CcSEcCtD
Fentanyl—Hypersensitivity—Carmustine—lymphatic system cancer	0.00022	0.000581	CcSEcCtD
Fentanyl—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00022	0.00058	CcSEcCtD
Fentanyl—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00022	0.00058	CcSEcCtD
Fentanyl—Pneumonia—Methotrexate—lymphatic system cancer	0.000218	0.000576	CcSEcCtD
Fentanyl—Vomiting—Bleomycin—lymphatic system cancer	0.000218	0.000575	CcSEcCtD
Fentanyl—Infestation—Methotrexate—lymphatic system cancer	0.000217	0.000573	CcSEcCtD
Fentanyl—Infestation NOS—Methotrexate—lymphatic system cancer	0.000217	0.000573	CcSEcCtD
Fentanyl—Drowsiness—Methotrexate—lymphatic system cancer	0.000217	0.000573	CcSEcCtD
Fentanyl—Depression—Methotrexate—lymphatic system cancer	0.000216	0.000571	CcSEcCtD
Fentanyl—Rash—Bleomycin—lymphatic system cancer	0.000216	0.00057	CcSEcCtD
Fentanyl—Dermatitis—Bleomycin—lymphatic system cancer	0.000216	0.000569	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000215	0.000568	CcSEcCtD
Fentanyl—Asthenia—Carmustine—lymphatic system cancer	0.000214	0.000566	CcSEcCtD
Fentanyl—Renal failure—Methotrexate—lymphatic system cancer	0.000213	0.000563	CcSEcCtD
Fentanyl—Stomatitis—Methotrexate—lymphatic system cancer	0.000212	0.000559	CcSEcCtD
Fentanyl—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000211	0.000557	CcSEcCtD
Fentanyl—Hypersensitivity—Vincristine—lymphatic system cancer	0.00021	0.000555	CcSEcCtD
Fentanyl—Sweating—Methotrexate—lymphatic system cancer	0.000208	0.000549	CcSEcCtD
Fentanyl—Haematuria—Methotrexate—lymphatic system cancer	0.000207	0.000546	CcSEcCtD
Fentanyl—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000205	0.000542	CcSEcCtD
Fentanyl—Epistaxis—Methotrexate—lymphatic system cancer	0.000205	0.00054	CcSEcCtD
Fentanyl—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000205	0.00054	CcSEcCtD
Fentanyl—Asthenia—Vincristine—lymphatic system cancer	0.000205	0.00054	CcSEcCtD
Fentanyl—Diarrhoea—Carmustine—lymphatic system cancer	0.000205	0.00054	CcSEcCtD
Fentanyl—Nausea—Bleomycin—lymphatic system cancer	0.000203	0.000537	CcSEcCtD
Fentanyl—Asthenia—Mitoxantrone—lymphatic system cancer	0.000199	0.000526	CcSEcCtD
Fentanyl—Dizziness—Carmustine—lymphatic system cancer	0.000198	0.000522	CcSEcCtD
Fentanyl—Haemoglobin—Methotrexate—lymphatic system cancer	0.000196	0.000517	CcSEcCtD
Fentanyl—Diarrhoea—Vincristine—lymphatic system cancer	0.000195	0.000515	CcSEcCtD
Fentanyl—Haemorrhage—Methotrexate—lymphatic system cancer	0.000195	0.000514	CcSEcCtD
Fentanyl—Pharyngitis—Methotrexate—lymphatic system cancer	0.000193	0.000511	CcSEcCtD
Fentanyl—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000192	0.000508	CcSEcCtD
Fentanyl—Urethral disorder—Methotrexate—lymphatic system cancer	0.000191	0.000504	CcSEcCtD
Fentanyl—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00019	0.000502	CcSEcCtD
Fentanyl—Vomiting—Carmustine—lymphatic system cancer	0.00019	0.000502	CcSEcCtD
Fentanyl—Dizziness—Vincristine—lymphatic system cancer	0.000189	0.000498	CcSEcCtD
Fentanyl—Rash—Carmustine—lymphatic system cancer	0.000188	0.000497	CcSEcCtD
Fentanyl—Dermatitis—Carmustine—lymphatic system cancer	0.000188	0.000497	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—lymphatic system cancer	0.000188	0.000496	CcSEcCtD
Fentanyl—Headache—Carmustine—lymphatic system cancer	0.000187	0.000494	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000184	0.000486	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—lymphatic system cancer	0.000182	0.000481	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—lymphatic system cancer	0.000182	0.00048	CcSEcCtD
Fentanyl—Vomiting—Vincristine—lymphatic system cancer	0.000181	0.000479	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000181	0.000477	CcSEcCtD
Fentanyl—Rash—Vincristine—lymphatic system cancer	0.00018	0.000475	CcSEcCtD
Fentanyl—Dermatitis—Vincristine—lymphatic system cancer	0.00018	0.000474	CcSEcCtD
Fentanyl—Headache—Vincristine—lymphatic system cancer	0.000179	0.000472	CcSEcCtD
Fentanyl—Nausea—Carmustine—lymphatic system cancer	0.000178	0.000469	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—lymphatic system cancer	0.000177	0.000467	CcSEcCtD
Fentanyl—Vomiting—Mitoxantrone—lymphatic system cancer	0.000177	0.000466	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—lymphatic system cancer	0.000176	0.000465	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000176	0.000464	CcSEcCtD
Fentanyl—Rash—Mitoxantrone—lymphatic system cancer	0.000175	0.000462	CcSEcCtD
Fentanyl—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000175	0.000462	CcSEcCtD
Fentanyl—Chills—Methotrexate—lymphatic system cancer	0.000175	0.000462	CcSEcCtD
Fentanyl—Headache—Mitoxantrone—lymphatic system cancer	0.000174	0.000459	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—lymphatic system cancer	0.000172	0.000455	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—lymphatic system cancer	0.000171	0.000451	CcSEcCtD
Fentanyl—Erythema—Methotrexate—lymphatic system cancer	0.00017	0.000448	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—lymphatic system cancer	0.00017	0.000448	CcSEcCtD
Fentanyl—Nausea—Vincristine—lymphatic system cancer	0.000169	0.000447	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—lymphatic system cancer	0.000166	0.000438	CcSEcCtD
Fentanyl—Nausea—Mitoxantrone—lymphatic system cancer	0.000165	0.000436	CcSEcCtD
Fentanyl—Back pain—Methotrexate—lymphatic system cancer	0.000164	0.000433	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—lymphatic system cancer	0.00016	0.000422	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000157	0.000415	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—lymphatic system cancer	0.000157	0.000414	CcSEcCtD
Fentanyl—Malaise—Methotrexate—lymphatic system cancer	0.000153	0.000404	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—lymphatic system cancer	0.000152	0.000402	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—lymphatic system cancer	0.000152	0.000401	CcSEcCtD
Fentanyl—Cough—Methotrexate—lymphatic system cancer	0.000148	0.000391	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—lymphatic system cancer	0.000147	0.000388	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—lymphatic system cancer	0.000144	0.000381	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—lymphatic system cancer	0.000144	0.000381	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—lymphatic system cancer	0.000144	0.000381	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000143	0.000379	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—lymphatic system cancer	0.000143	0.000377	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—lymphatic system cancer	0.00014	0.000368	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000138	0.000365	CcSEcCtD
Fentanyl—Infection—Methotrexate—lymphatic system cancer	0.000138	0.000363	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000136	0.000358	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000136	0.000358	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—lymphatic system cancer	0.000134	0.000355	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000134	0.000353	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—lymphatic system cancer	0.000132	0.000348	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—lymphatic system cancer	0.000129	0.000341	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000126	0.000333	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—lymphatic system cancer	0.000125	0.000331	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—lymphatic system cancer	0.000124	0.000328	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—lymphatic system cancer	0.000123	0.000326	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—lymphatic system cancer	0.000123	0.000325	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—lymphatic system cancer	0.000122	0.000322	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—lymphatic system cancer	0.00012	0.000318	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00012	0.000315	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—lymphatic system cancer	0.000119	0.000315	CcSEcCtD
Fentanyl—Pain—Methotrexate—lymphatic system cancer	0.000118	0.000313	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000114	0.000301	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000113	0.000299	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—lymphatic system cancer	0.00011	0.00029	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—lymphatic system cancer	0.000109	0.000289	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—lymphatic system cancer	0.000109	0.000289	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000102	0.000269	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—lymphatic system cancer	9.93e-05	0.000262	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—lymphatic system cancer	9.8e-05	0.000259	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—lymphatic system cancer	9.47e-05	0.00025	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—lymphatic system cancer	9.16e-05	0.000242	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—lymphatic system cancer	8.8e-05	0.000232	CcSEcCtD
Fentanyl—Rash—Methotrexate—lymphatic system cancer	8.73e-05	0.00023	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—lymphatic system cancer	8.72e-05	0.00023	CcSEcCtD
Fentanyl—Headache—Methotrexate—lymphatic system cancer	8.67e-05	0.000229	CcSEcCtD
Fentanyl—Nausea—Methotrexate—lymphatic system cancer	8.22e-05	0.000217	CcSEcCtD
